- call +1-201-465-4211
- email sales@mrinsights.biz
Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.
Scope of the Report:
The human papillomavirus (HPV) test detects the presence of human papillomavirus, a virus that can lead to the development of genital warts, abnormal cervical cells or cervical cancer. The HPV testing is further classified into three sub-segments, namely, follow-up testing, co-testing, HPV primary testing.
PV Testing is mainly used in Cervical Cancer Screening. Cervical Cancer Screening is the biggest application. The main suppliers of HPV testing in the market include Qiagen, Roche Diagnostics, Hologic, Abbott Laboratories, BD and Seegene, Inc., Qiagen is the biggest supplier, in 2016 Qiagen revenue was about $ 194.13 million and in 2017 Qiagen revenue will be about $ 204.06 million.Global HPV testing market can be divided into two big markets: Europe and North America. North America is the largest HPV testing region, in 2016, North America HPV testing revenue was about $ 248.12 million in 2016, in 2017, USA HPV testing revenue will be about $ 270.49 million.
The global Human Parainfluenza Viruses Diagnostics market is valued at 580 million USD in 2017 and is expected to reach 940 million USD by the end of 2023, growing at a CAGR of 8.4% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Parainfluenza Viruses Diagnostics.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
This report studies the Human Parainfluenza Viruses Diagnostics market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Parainfluenza Viruses Diagnostics market by product type and applications/end industries.
Market Segment by Companies, this report covers
Qiagen
Roche Diagnostics
Hologic
Abbott Laboratories
BD
Seegene
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
HPV Testing
Follow-up HPV Testing
Co-testing
Market Segment by Applications, can be divided into
Cervical Cancer Screening
Vaginal Cancer Screening
Other
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Human Parainfluenza Viruses Diagnostics Market Overview
1.1 Product Overview and Scope of Human Parainfluenza Viruses Diagnostics
1.2 Classification of Human Parainfluenza Viruses Diagnostics by Types
1.2.1 Global Human Parainfluenza Viruses Diagnostics Revenue Comparison by Types (2017-2023)
1.2.2 Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Types in 2017
1.2.3 HPV Testing
1.2.4 Follow-up HPV Testing
1.2.5 Co-testing
1.3 Global Human Parainfluenza Viruses Diagnostics Market by Application
1.3.1 Global Human Parainfluenza Viruses Diagnostics Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Cervical Cancer Screening
1.3.3 Vaginal Cancer Screening
1.3.4 Other
1.4 Global Human Parainfluenza Viruses Diagnostics Market by Regions
1.4.1 Global Human Parainfluenza Viruses Diagnostics Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Human Parainfluenza Viruses Diagnostics Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Parainfluenza Viruses Diagnostics Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Parainfluenza Viruses Diagnostics Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Human Parainfluenza Viruses Diagnostics Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Parainfluenza Viruses Diagnostics Status and Prospect (2013-2023)
1.5 Global Market Size of Human Parainfluenza Viruses Diagnostics (2013-2023)
2 Manufacturers Profiles
2.1 Qiagen
2.1.1 Business Overview
2.1.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Qiagen Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.2 Roche Diagnostics
2.2.1 Business Overview
2.2.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Diagnostics Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.3 Hologic
2.3.1 Business Overview
2.3.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Hologic Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.4 Abbott Laboratories
2.4.1 Business Overview
2.4.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Abbott Laboratories Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.5 BD
2.5.1 Business Overview
2.5.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 BD Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
2.6 Seegene
2.6.1 Business Overview
2.6.2 Human Parainfluenza Viruses Diagnostics Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Seegene Human Parainfluenza Viruses Diagnostics Revenue, Gross Margin and Market Share (2016-2017)
3 Global Human Parainfluenza Viruses Diagnostics Market Competition, by Players
3.1 Global Human Parainfluenza Viruses Diagnostics Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Human Parainfluenza Viruses Diagnostics Players Market Share
3.2.2 Top 10 Human Parainfluenza Viruses Diagnostics Players Market Share
3.3 Market Competition Trend
4 Global Human Parainfluenza Viruses Diagnostics Market Size by Regions
4.1 Global Human Parainfluenza Viruses Diagnostics Revenue and Market Share by Regions
4.2 North America Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
4.3 Europe Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
4.5 South America Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
5 North America Human Parainfluenza Viruses Diagnostics Revenue by Countries
5.1 North America Human Parainfluenza Viruses Diagnostics Revenue by Countries (2013-2018)
5.2 USA Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
5.3 Canada Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
5.4 Mexico Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
6 Europe Human Parainfluenza Viruses Diagnostics Revenue by Countries
6.1 Europe Human Parainfluenza Viruses Diagnostics Revenue by Countries (2013-2018)
6.2 Germany Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
6.3 UK Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
6.4 France Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
6.5 Russia Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
6.6 Italy Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue by Countries
7.1 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue by Countries (2013-2018)
7.2 China Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
7.3 Japan Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
7.4 Korea Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
7.5 India Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
8 South America Human Parainfluenza Viruses Diagnostics Revenue by Countries
8.1 South America Human Parainfluenza Viruses Diagnostics Revenue by Countries (2013-2018)
8.2 Brazil Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
8.3 Argentina Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
8.4 Colombia Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Human Parainfluenza Viruses Diagnostics by Countries
9.1 Middle East and Africa Human Parainfluenza Viruses Diagnostics Revenue by Countries (2013-2018)
9.2 Saudi Arabia Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
9.3 UAE Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
9.4 Egypt Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
9.5 Nigeria Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
9.6 South Africa Human Parainfluenza Viruses Diagnostics Revenue and Growth Rate (2013-2018)
10 Global Human Parainfluenza Viruses Diagnostics Market Segment by Type
10.1 Global Human Parainfluenza Viruses Diagnostics Revenue and Market Share by Type (2013-2018)
10.2 Global Human Parainfluenza Viruses Diagnostics Market Forecast by Type (2018-2023)
10.3 HPV Testing Revenue Growth Rate (2013-2023)
10.4 Follow-up HPV Testing Revenue Growth Rate (2013-2023)
10.5 Co-testing Revenue Growth Rate (2013-2023)
11 Global Human Parainfluenza Viruses Diagnostics Market Segment by Application
11.1 Global Human Parainfluenza Viruses Diagnostics Revenue Market Share by Application (2013-2018)
11.2 Human Parainfluenza Viruses Diagnostics Market Forecast by Application (2018-2023)
11.3 Cervical Cancer Screening Revenue Growth (2013-2018)
11.4 Vaginal Cancer Screening Revenue Growth (2013-2018)
11.5 Other Revenue Growth (2013-2018)
12 Global Human Parainfluenza Viruses Diagnostics Market Size Forecast (2018-2023)
12.1 Global Human Parainfluenza Viruses Diagnostics Market Size Forecast (2018-2023)
12.2 Global Human Parainfluenza Viruses Diagnostics Market Forecast by Regions (2018-2023)
12.3 North America Human Parainfluenza Viruses Diagnostics Revenue Market Forecast (2018-2023)
12.4 Europe Human Parainfluenza Viruses Diagnostics Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Human Parainfluenza Viruses Diagnostics Revenue Market Forecast (2018-2023)
12.6 South America Human Parainfluenza Viruses Diagnostics Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Human Parainfluenza Viruses Diagnostics Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Human Parainfluenza Viruses Diagnostics Picture
Table Product Specifications of Human Parainfluenza Viruses Diagnostics
Table Global Human Parainfluenza Viruses Diag
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
